March 17, 2023, 2 p.m. | MIT Technology Review Insights

MIT Technology Review www.technologyreview.com

Regeneron Pharmaceuticals, a biotechnology company that develops life-transforming medicines, found itself inundated with vast volumes of data during the peak of the covid-19 pandemic. In order to derive actionable information from these disparate data sets, which ranged from clinical trial data to real-time supply chain information, the company needed new ways to join and relate…

biotechnology clinical trial computing covid covid-19 covid-19 pandemic data data sets information join life medicines pandemic paradigm peak pharmaceuticals real-time sponsored supply chain

More from www.technologyreview.com / MIT Technology Review

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Software Engineering Manager, Generative AI - Characters

@ Meta | Bellevue, WA | Menlo Park, CA | Seattle, WA | New York City | San Francisco, CA

Senior Operations Research Analyst / Predictive Modeler

@ LinQuest | Colorado Springs, Colorado, United States